UMESH MEHTA: Open Payments
NPI 1316903818 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 17 payments from 5 companies in 2025. Trend: 2023 $345 · 2024 $384 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $164 |
| Lundbeck LLC | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: VRAYLAR, REXULTI, UZEDY, ABILIFY MAINTENA, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
